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Abstract: 
Biofuels are a commercial reality with ethanol comprising approximately 10% of the US retail fuel market, and 
biodiesels contribute a little under 5% to the EU retail fuel market. These biofuels molecules are derived from the 
fermentation of sugars by yeast (ethanol), and from the chemical modification of animal fats and plant oils 
(biodiesel). However, these biofuel molecules are chemically distinct from the petroleum fuels that they are 
blended with. Petroleum-based fuels are predominantly composed of alkane and alkene hydrocarbons. These 
differences impact on fuel properties and infrastructure compatibility resulting in a ‘blend wall’ that - without 
significant infrastructure re-alignment and associated costs - limits the use of biofuels. For this reason, there is 
great interest in biosynthetic routes for alkane and alkene production. Here we will review the known biological 
routes to alka/ene biosynthesis with a focus on bacterial alkane and alkene biosynthetic pathways. Specifically, we 
will review pathways for which the underlying genetic components have been identified. We will also investigate 
the development of engineered metabolic pathways that permit the production of alkanes and alkenes that are not 
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naturally synthesised in bacteria (heterologous production), but are suitable for industrial commercial application. 
Finally, we will highlight some of the challenges facing this research area as it moves from proof-of-principle 
studies towards industrialisation. 
1. Introduction 
Biogenic production of alkane and alkene hydrocarbons has received much attention in recent years. This is 
largely driven by the growth of the biofuels sector in response to climate change legislation and fuel security 
concerns. Current retail biofuels fall into two categories: alcohols (primarily ethanol) that are blended with petrol, 
and both fatty acid ethyl esthers (FAEEs) and fatty acid methyl esthers (FAMEs) that are blended with diesel to 
form fatty-acid derived biodiesel. Ethanol is produced predominantly by yeast fermentation and is mixed with 
petrol (gasoline). Biodiesels, derived from animal fats or plant oils, are mixed with diesel. These first-generation 
biofuels, most notably ethanol, have demonstrated a rapid increase in their penetration of the fuel market. In the 
US for example, ethanol content in petrol rose from little over 1% in 2001 to nearly 10% within a decade. Six 
years later, however, and ethanol remains at approximately 10% of the market. The failure to penetrate the fuel 
market further is in part due to the challenges that these biofuel molecules present to the fuel sector. They are not 
wholly compatible with our petroleum-focussed infrastructure. Ethanol, for example is hygroscopic, meaning that 
it has a high tendency to absorb water from the air. The presence of water makes it corrosive to transport 
infrastructure and reduces the heat of fuel combustion. Biodiesel is also moderately hygroscopic, and, if not 
blended correctly, can form waxes within fuels at cool temperatures. Both of these biofuels therefore have 
limitations imposed on the ratio of biofuel to petroleum - the so called ‘blend wall’. This is typically in the region 
of 10-15%. It is to circumvent this blend wall that there has been a renewed interest in alkane biogenesis. 
Alkane and alkene hydrocarbon molecules are chemically and structurally identical to the molecules 
found within petroleum-based fuels (Fig. 1). As such there is no theoretical or practical limitation on their 
inclusion within current transport infrastructure. Within the last decade, the underlying genetic components of 
alkane biogenesis have been discovered in diverse species from across all kingdoms. This knowledge is in turn 
permitting a greater understanding of the biochemical processes involved and spurring the search for further 
discoveries. Coupled to this ‘discovery-focussed’ effort, there are significant advances in engineering natural 
biosynthetic pathways to produce alkanes and alkenes in microbial hosts, such as Escherichia coli and 
Saccharomyces cerevisiae. The aim of this research is to improve yields and to direct carbon flux towards 
infrastructure-compatible molecules - so called ‘drop-in’ biofuels. This chapter will review current knowledge of 
the underlying genetic and biochemical basis for alka/ene biogenesis in bacteria, and will describe efforts to 
manipulate these biological systems to develop metabolic pathways that can produce alkane and alkene 
hydrocarbons tailored to the specific requirements of our transport infrastructure. The biosynthesis of other 
hydrocarbon molecules, for example isoprenoids, will not be considered here, nor will we review the extensive 
literature manipulating and enhancing fatty acid biosynthesis. For reviews on these topics see Schrader and 
Bohlmann (2015) and Mehrer et al. (2016) respectively. 
2. Natural alkane biosynthetic pathways 
Biogenic sources of alkane have been known for some considerable time (Albro and Dittmer 1969a, b), and 
alkane biosynthesis can be observed across the biological domains. Examples include alkanes as components in 
waxes of plants (Bernard et al. 2012) and animals (Cheesbrough and Kolattukudy 1988), in storage reserves and 
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membrane components of microalgae (Dennis and Kolattukudy 1992; Grossi et al. 2000; Sorigue et al. 2016) and 
in pheromones, defence compounds and cuticular waxes of insects (Howard 1982; Howard et al. 1982; Reed et al. 
1994; Tillman et al. 1999; Qiu et al. 2012). Alkanes are also known to be synthesised in fungi (Griffin et al. 2010; 
Gianoulis et al. 2012; Spakowicz and Strobel 2015) and in many bacterial species (McInnes et al. 1980; Beller et 
al. 2010; Schirmer et al. 2010; Sukovich et al. 2010b; Rude et al. 2011) though their physiological roles are less 
well understood. In eukaryotic systems, the genetic components have been identified in plant cuticular wax 
biosynthesis and in fruit fly wax biosynthesis. In plants, very long chain (VLC) alkanes are an integral component 
of the waxy cuticle, comprising up to 70% of the cuticle in the model species Arabidopsis thaliana. VLC alkanes 
have a carbon chain length (Cn) of between C20 and C36. In Arabidopsis, the proteins ECERIFERUM1 (CER1), 
ECERIFERUM3 (CER3) and the endoplasmic reticulum-associated cytochrome b5 isoform CYTB5s interact to 
enable the conversion of fatty acids to VLC alkanes (Bourdenx et al. 2011; Bernard et al. 2012). This proposed 
conversion is via a fatty acyl-CoA intermediate, with the subsequent release of CO. Clear evidence for the role of 
CER1/CER3 and CYTB5 has been demonstrated by the reconstitution of this pathway in the yeast, S. cerevisiae 
and the resulting production of VLC alkanes (Bernard et al. 2012). Within the fruit fly Drosophila melanogaster, 
a P450 enzyme of the CYP4G family oxidatively produces alkanes from fatty aldehydes (Qiu et al. 2012). The 
enzyme reaction allows the production of the alkane heptadecane from the fatty aldehyde octadecanal, with the 
release of CO2. The biochemical and genetic mechanisms underlying the production of alkanes and alkenes in 
other eukaryotic systems remain to be elucidated. In this section, we will review the remainder of the alkane and 
alkene biosynthetic pathways for which the genetic components have been identified (Fig. 2). All of these 
biogenic routes are found within bacteria. They include the cyanobacterial biosynthesis of alkanes and alkenes 
(section 2.1) catalysed by an acyl-[acyl carrier protein] (ACP) reductase and an aldehyde deformylase oxygenase, 
the production of VLC alkanes (section 2.2) via the oleABCD gene cluster, and the production of mid-chain length 
terminal alkenes (2.3) that can be accomplished via three independent mechanisms. 
 
2.1 Cyanobacterial biosynthesis of alkanes and alkenes 
The discovery and elucidation of a two-step alkane biosynthetic pathway in cyanobacteria stimulated a renewed 
interest in alkane biosynthesis (Schirmer et al. 2010). The cyanobacterial alkane biosynthetic pathway comprises a 
two-step reaction involving firstly, the reduction of intermediates of fatty acid biosynthesis (specifically the 
growing fatty acyl-ACP chain) to a fatty aldehyde, and secondly, the deformylation of the fatty aldehyde to an Cn-
1 alkane or alkene (Das et al. 2011; Warui et al. 2011). The genes responsible for this reaction were discovered 
through a subtractive genomics approach (Schirmer et al. 2010). Cyanobacteria benefit from reproducible reports 
of alkane biosynthesis (Winters et al. 1969) and the availability of whole genome sequences. An assessment of 11 
cyanobacterial species for their ability to make alkanes in culture identified ten that could synthesise alkanes and 
one that could not. Subtractive analysis of the available genomes identified 17 genes common to all species that 
produced alkanes but absent in the one species that did not. While it was possible to assign biological functions to 
ten of these genes, seven candidates remained without clear biological roles. Of these seven, two of these genes 
were hypothesised as likely candidates and as a result they were cloned from Synechococcus elongatus PCC7942. 
These were orf1594 and orf1593. They were expressed in E. coli and, when combined, the result was the 
biosynthesis of heptadecane (C17) and pentadecane (C15) (Fig. 1A). Further investigations of homologs of orf1594 
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and orf1593 in other cyanobacteria identified this to be the common genetic basis for alkane biosynthesis across 
all cyanobacteria investigated within this study (Schirmer et al. 2010). 
 The two genes, orf1594 and orf1593, encode an acyl-ACP reductase (AAR) and an aldehyde 
deformylating oxygenase (ADO) respectively (Fig. 2A) (Schirmer et al. 2010; Das et al. 2011; Eser et al. 2011). 
Both AAR and ADO are soluble enzymes and the reactions proceed in the cytosol, in contrast to the Arabidopsis 
CER1/CER3/CYTB5s and Drosophila CYP4G proteins which are membrane associated. The ADO enzyme is 
responsible for generating alkanes from fatty aldehydes, though it can also generate Cn-1 fatty aldehydes and 
alcohols (Aukema et al. 2013). Initially, it was suggested that the decarbonylation of fatty aldehyde produces 
carbon monoxide as a by-product (Schirmer et al. 2010). Further investigations with Nostoc punctiforme ADO 
heterologously expressed in E. coli have indicated that the by-product was in fact formate (Warui et al. 2011). The 
cyanobacterial ADO is a member of the non-heme dinuclear iron oxygenase family of enzymes. This family of 
enzymes use molecular oxygen and a reducing system, typically ferredoxin, ferredoxin oxidoreductase and 
NADPH, to reduce the enzyme at the start of each reaction. Initially, studies of ADO from Prochlorococcus 
marinus MIT9313, heterologously expressed and purified from E. coli, indicated that the reaction mechanism also 
produces formate and alkane under anaerobic conditions (Das et al. 2011). Other experiments on N. punctiforme, 
Synechococcus sp RS9917 and Synechococcus sp PCC6803 also exhibited alkane biosynthesis in anaerobic 
conditions (Eser et al. 2011). It was therefore thought that the enzyme may convert fatty aldehydes to alkane in 
the absence of molecular oxygen. If ADO operates in the absence of oxygen it was hypothesised that water 
provides the oxygen required for the formation of formate (Eser et al. 2011). Radiolabelling studies with 18O-
water suggested that a hydrolytic event was solely responsible for the conversion of fatty aldehyde to its 
corresponding n-1alkane and formate (Eser et al. 2011). A reducing system is still required even under anaerobic 
conditions and reaction rates were further improved using a non-physiological reducing system, 5-
methylphenazinium methylsulphate (PMS):NADPH as opposed to the ferredoxin system (Eser et al. 2011). In 
direct contradiction to these investigations, an equivalent study with ADO from N. punctiforme suggested an 
absolute dependence on molecular oxygen (Li et al. 2011) Later studies have confirmed this view, with labelled 
18O2 and 18O-water demonstrating a strict dependence of ADO on molecular oxygen with P. marinus and N. 
punctiforme orthologs (Li et al. 2012). The discrepancy with the early work was attributed to oxygen 
contamination in a supposedly anoxic condition during enzymatic assays. To reflect the formation of formate and 
use of oxygen, the original nomenclature for the enzyme aldehyde decarbonylase has been changed to aldehyde 
deformylating oxygenase. 
Catalytic turnover of ADO is incredibly slow in vitro with single turnover rates measured in hours (Das 
et al., 2011; Eser et al., 2011; Warui et al., 2011). Solubility of the substrate may play a part in the slow turnover 
rates, as even at low concentrations long substrates such as octadecanal forms micelles. Low rates are typical for 
enzymes that catalyse reactions involving insoluble substrates. Shorter chain length substrates, such as heptanal, 
are also suitable substrates (Eser et al., 2011). There are also improvements in rates when the reaction is 
reconstituted in the presence of the endogenous cyanobacterial reducing system (Zhang et al., 2013). Reaction 
rates in these circumstances can be measured at 0.4 min-1 against octadecanal. The low activity and stability of the 
ADO presents a significant challenge for its deployment in metabolic engineering, though it has undoubtedly 
proven a popular choice of enzyme for alkane biosynthesis.  
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2.2 Very-long chain (VLC) alkene biosynthesis 
The presence of VLC alkenes has been reported in many Gram-positive and Gram-negative bacteria (Sukovich et 
al. 2010a), including in Sarcina lutea (Albro and Dittmer 1969a, b), Micrococcus luteus (Beller et al. 2010), 
Arthrobacter aurescens (Frias et al. 2009), Stenotrophomonas maltophilia (Bonnett et al. 2011) and Shewanella 
species (Sugihara et al. 2010; Sukovich et al. 2010b). These alkenes typically fall into the range C25 to C33 and can 
be highly unsaturated molecules. The highly unsaturated alkene identified in Shewanella is shown in Fig. 1B. The 
biosynthesis of these long chain hydrocarbons is proposed to be important in maintaining membrane integrity, 
particularly in marine environments and cold conditions (Nichols et al. 1995; Sukovich et al. 2010b). This 
function is not restricted to bacterial membranes, with similar physiological function proposed in some unicellular 
marine eukaryotes (Grossi et al. 2000).  The genes responsible have been termed ole genes (the name derived 
from olefin synthesis) and biosynthesis of alkenes requires the presence of three or four genes, oleA, oleB, oleC 
and oleD (Sukovich et al. 2010a; Christenson et al. 2017a). A combination of biochemical deduction and genome 
analysis was responsible for the identification of three ole genes in M. luteus (Beller et al. 2010). In this instance, 
research benefited from well-documented alkene biosynthesis in the closely related S. lutea species (Albro and 
Dittmer 1969a, b). The pathway in S. lutea was hypothesised to involve an initial decarboxylation of a fatty acyl-
CoA substrate, followed by a ‘head-to-head’ condensation reaction. The availability of the genome from the 
closely related M. luteus allowed searches for homologs of enzymes involved in condensing reactions in fatty acid 
biosynthesis to identify three candidate genes (Beller et al. 2010). Of these, one corresponded closely to the β-
ketoacyl-ACP synthase II (KASII) gene fabF and another corresponded to the β-ketoacyl-ACP synthase III 
(KASIII) gene fabH. These two genes were also present in a six-gene cluster encoding several other enzymes of 
fatty acid biosynthesis, strongly suggesting their role was in the synthesis of fatty acids rather than alkenes. The 
third gene, Mlut_13230, was also homologous to fabH but the sequence similarity diverged to a greater extent 
than the other candidate gene. Heterologous expression of these candidate genes in E. coli did not result in the 
production of alkenes. Careful examination of the metabolite profile of E. coli expressing Mlut_13230 however 
did reveal the appearance of monoketones. This is consistent with the proposed mechanism of alkene 
biosynthesis. As a result, further analysis of the M. luteus genome revealed that Mlut_13230 is present as part of a 
three-gene cluster, comprising Mlut_13230, Mlut_13240 and Mlut_13250. It was shown that expression of all 
three of the genes in this gene cluster in E. coli results in the biosynthesis of VLC alkenes (Beller et al. 2010). 
In two similar studies, VLC alkenes were identified in Shewanella oneidensis (Sukovich et al. 2010b) 
and Shewanella sp. strain osh08 (Sugihara et al. 2010). The principal alkene produced was a highly unsaturated 
molecule, containing nine C=C double bonds. NMR and GC/MS analysis revealed it to be 
3,6,9,12,15,19,22,25,28-hentriacontanonaene, shown in Fig. 1A. Genetic evidence indicates that the production of 
this alkene in Shewanella requires the biosynthesis of poly-unsaturated fatty acids (PUFAs). Strains in which 
PUFA biosynthesis is inhibited through the removal of key PUFA biosynthetic genes are unable to synthesise 
alkenes (Sugihara et al. 2010; Sukovich et al. 2010b). Unlike in M. luteus, however, Shewanella alkene 
biosynthesis requires four genetic components. One of the proteins identified in S. oneidensis, gi 24373309, has a 
31% homology at the amino acid level to Mlut_13230. Another, identified in S. oneidensis as gi 24373312, shows 
31% homology to Mlut_13250, while the two remaining proteins both have homology to Mlut_13240 from M. 
luteus. In fact, on closer examination it is evident that Mlut_13240 is a fusion protein of these proteins (Beller et 
al. 2010; Sukovich et al. 2010b). Genomic analysis indicates that the occurrence of this type of ‘head-to-head’ 
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condensation is widespread in bacteria and different genomic arrangements have been described (Sukovich et al. 
2010a). It is now recognised that the oleABCD gene cluster encodes the following enzymes: oleA encodes a 
thiolase, oleB encodes an alpha/beta hydrolase, oleC encodes an AMP-dependent ligase/synthase and oleD 
encodes short chain dehydrogenase/reductase. None of the ole genes have yet been identified in the Archaea or 
Eukaryota (Sukovich et al. 2010a). 
The biosynthesis of these VLC alkenes commences with the reaction catalysed by the OleA thiolase (Fig. 
2B). In this reaction, the non-decarboxylative Claisen condensation of two fatty acyl-CoA molecules, such as 
tetradecanoyl-CoA (C14), results in the production of a C27 β-keto acid, 2-myristoylmyristic acid (Frias et al. 
2011). The next step, catalysed by OleD, an NADPH-dependent 2-alkyl-3-ketoalkanoic acid reductase results in 
the production of a hydroxyl alkanoic acids (Bonnett et al. 2011). Finally, OleC has been shown generate a 
thermally labile β -lactone which can spontaneously, and non-biologically decarboxylate to an alkene. However, it 
is currently believed that this final reaction is catalysed in vivo by OleB - a β-lactone decarboxylase (Kancharla et 
al. 2016; Christenson et al. 2017b). Recent evidence indicates that OleB, OleC and OleD enzymes assemble into a 
large, multiprotein complex (Christenson et al. 2017a). It is proposed that such a configuration retains the highly 
reactive beta-lactone intermediate produced by the OleC-catalysed reaction from unwanted reactions - such multi-
protein complexes are observed across the biological domains (for examples see Singleton et al. (2014). Genetic 
tools available in S. oneidensis permit the removal of the endogenous oleA gene and its replacement with 
homologs from other species. When oleA is replaced with the equivalent gene from S. maltophilia there is an 
alteration in the alkene profile. In the wild type strain, 3,6,9,12,15,19,22,25,28-hentriacontanonaene is the sole 
product, whereas in the modified strain an abundance of more saturated monoketones is produced (Sukovich et al. 
2010b). Likewise, swapping in oleA genes from a range of diverse bacteria alters the hydrocarbon profile in such a 
way that it resembles the hydrocarbon profile from the donor oleA, rather than the host S. oneidensis (Sukovich et 
al. 2010a). 
 
2.3 Biosynthesis of mid-chain length alkenes 
The third example of hydrocarbon biogenesis in bacteria is the production of mid-chain length terminal alkenes 
and there are three distinct genetic examples of how this may be achieved. These include their production via 
cytochrome P450-catalysed reactions in Jeotgalicoccus sp. (Rude et al. 2011), via a non-heme iron oxidase in 
Pseudomonas aeruginosa (Rui et al. 2014) and via a modular polyketide synthase (PKS) in Synechococcus sp. 
(Mendez-Perez et al. 2011; Mendez-Perez et al. 2014). These reactions produce mid-chain length 1-alkenes far 
shorter than those described in section 2.2, with chain lengths typically in the region of C10 (for the non-heme iron 
oxidase) and C18 to C20 (for the P450 and PKS reactions). Mid-chain length terminal alkenes are of interest not 
just for their fuel properties but also, because they can be readily derivatised, they are important precursor 
molecules for commodity chemicals such as plastics, lubricants and detergents. 
A reverse genetics approach was used to isolate the genes responsible for medium chain length (C18 to 
C20) alkene biosynthesis in Jeotgalicoccus sp. (Rude et al. 2011). Jeotgalicoccus species are low GC Gram 
positive firmicutes. Analysis of micrococci reported to produce alkenes revealed several that produced very long 
chain alkenes (as discussed in section 2.2) and one that produced medium chain length alkenes. This ability to 
produce medium chain length alkenes rather than VLC alkenes was identified in a Jeotgalicoccus species, and 
subsequent investigation revealed this was a common feature in many Jeotgalicoccus species. Both feeding assays 
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- in which media were supplemented with fatty acids - and the ability of crude cell lysates to convert fatty acids to 
the corresponding Cn-1 alkenes, suggested direct activity on fatty acids (Rude et al. 2011). Importantly, the ability 
to assay alkene production in this manner permits protein purification and fractionation experiments. As a result, 
fractions of partially purified proteins with the ability to convert fatty acids to alkenes were identified that 
contained two candidate proteins. One of these was identified as orf880, and heterologous expression of orf880 in 
E. coli resulted in the production of pentadecene and 1,10-heptadecadiene. The gene was termed oleT and it 
encodes an enzyme that is a cytochrome P450 fatty acid peroxygenase (Rude et al. 2011), specifically a member 
of the cyp152 subfamily of P450s. They are found in a diverse range of bacteria, including many that catalyse the 
hydroxylation of fatty acids. Members of this family are active using H2O2, rather than O2, NADPH or other redox 
partners. OleTJE has been shown to catalyse the formation of Cn-1 alkenes through the H2O2-dependent 
decarboxylation of C12, C14, C16, C18 and C20 saturated fatty acids (Belcher et al. 2014). Other P450s known with 
similar activity include a P450 from Rhodotorula minuta that converts isovalerate to isobutene (Fukuda et al. 
1994). 
Another pathway for the biosynthesis of mid-chain length alkenes is found in P. aeruginosa (Rui et al. 
2014). Discovery of the gene responsible for the biosynthesis of the 11-carbon semi-volatile 1-undecane began 
with feeding labelled putative substrates [12-13C]dodecanoic acid and [1-13C] dodecanoic acid to P. aeruginosa 
cultures. The result was the production of [12-13C]undecene and [U-12C11]undecene, a result that confirmed both 
the substrate (fatty acid), and that the terminal carboxylic acid moiety is removed in the reaction (Rui et al. 2014). 
A high-throughput screen of approximately 6000 fosmid-containing E. coli cultures was employed and identified 
a single gene for 1-undecene production, termed undA. UndA is a small protein of 261 amino acids. Biochemical 
analysis reveals that Fe2+ is essential for its function in vitro. Moreover, whilst the dominant function in vivo 
appears to be the production of 1-undecene, it is also capable of acting on fatty acids in the range of C10 to C14. 
The reaction is proposed to proceed via the sequential binding of the carboxylate moiety of the fatty acid to 
ferrous iron within UndA, followed by binding of O2 to form a Fe(III) superoxide complex. Electron transfer 
results in the production of 1-undecene, CO2 and H2O and the reduction of an unstable Fe(IV)=O species. 
Importantly, unlike AAR/ADO and the oleABCD pathway, both OleTJE and UndA work directly on fatty acid 
substrates to produce the corresponding Cn-1 alkene in a single enzyme catalysed reaction. 
Finally, 1-alkene production by a modular synthase-encoding gene from Synechococcus sp. PCC 7002 
has been reported (Mendez-Perez et al. 2011; Mendez-Perez et al. 2014). Synechococcus sp. 7002 has been 
demonstrated to produce C19:1 and C19:2 alkenes, but interestingly, the largest fatty acid detected from 
Synechococcus sp. 7002 is a C18 fatty acid. This suggests that the mechanism is not analogous to the various Cn-1 
mechanisms for generating mid-chain length terminal alkenes, or the cyanobacterial ADO mechanism. Rather, an 
elongation-decarboxylation mechanism is proposed (Mendez-Perez et al. 2011; Mendez-Perez et al. 2014). The 
ols gene (olefin synthesis) was identified as a putative candidate, and ∆ols strains did not contain alkenes. The Ols 
system comprises a single, multi-domain protein, and is found in only a small number of cyanobacteria (Xie et al. 
2017). The biochemical steps are yet to be fully elucidated. 
3. Synthetic alkane biosynthetic pathways 
The identification of genetic components responsible for alkane biosynthesis across the biosphere is the crucial 
first step in the production of petroleum-replica hydrocarbons by microbial fermentation. However, the demands 
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the fuel industry places on the chemical and structural diversity for alkanes are not the same as the evolutionary 
pressure that has led to the biochemistry capable of biosynthesising alkanes (Rude and Schirmer 2009; Jimenez-
Diaz et al. 2017). Natural biosynthetic routes predominantly produce very long chain alkanes (e.g. A. thaliana, M. 
luteus), terminal alkenes (oleT) or a narrow range of linear alkanes (dominated by C17 and C15 in cyanobacteria). 
For alkane biosynthesis to be of commercial relevance, as well as biological interest, novel pathways must be 
developed that permit the production of the range and diversity of chemicals blended in fuel. 
 
3.1 Altering starting substrates 
The alkane profile of organisms is greatly influenced by the first step in the alkane biosynthetic pathway. For 
example, the cyanobacterial enzyme AAR reveals a preference for C18 over C16 fatty acyl-ACPs (Schirmer et al. 
2010; Howard et al. 2013), while the nature of the OleA present in Shewanella greatly affects the resulting alkane 
profile (Sukovich et al. 2010a). The ability to manipulate the output of alkane biosynthetic pathways will therefore 
be impacted by the ability to control which acyl chains enter the biosynthetic pathway. As a result, many groups 
have successfully identified novel routes for providing fatty aldehydes for alkane biosynthesis. 
 In one study, the fatty acid reductase (FAR) complex from Photorhabdus luminescens, used to provide 
fatty aldehyde for bacterial luminescence, replaced the activity of AAR in an engineered E. coli (Howard et al. 
2013). The P. luminescens FAR complex (encoded by luxCDE) exploits fatty acids, fatty acyl-CoAs and fatty 
acyl-ACP molecules to generate fatty aldehydes (Meighen 1998), thereby widening the pool of substrates 
available to feed into alkane biosynthesis. When coupled with the activity of ADO, there was a change in the 
abundance and composition of the alkane profile that more closely reflected the composition of the fatty acid 
profile than did the reconstituted AAR/ADO pathway (Howard et al. 2013). In two further examples, the 
carboxylic acid reductase (CAR), a large, single chain polypeptide from Mycobacterium marinum (Akhtar et al. 
2013) and a fatty acyl-CoA reductase from Acinetobacter sp. M-1 (Yan et al. 2016) were coupled with ADO to 
enable the used of free fatty acid pools, rather than fatty acyl-ACP, as starting substrate. By using fatty acids 
rather than fatty acyl-ACP, the nature of the alkanes produced can be altered, and any future metabolic 
engineering strategies can benefit from the extensive literature on improving fatty acid yields in bacteria. 
 Another study exploited the plant alkane biosynthetic system, rather than ADO but also permitted access 
to the fatty acid pool in E. coli (Choi and Lee 2013). In this instance, the authors increased the natural ability of E. 
coli cells to produce fatty acyl-CoAs from fatty acids, via fatty acyl-CoA synthetase (FadD), and coupled this 
activity with a fatty acyl-CoA reductase (ACR) activity from Clostridium acetobutylicum to reduce fatty acyl-
CoAs to fatty aldehydes. The final conversion of these aldehydes to alkanes was completed following addition of 
an E. coli codon-optimised Arabidopsis CER1 gene. This report is important in two respects. Firstly, previous 
attempts to heterologously express an active CER1 protein had been unsuccessful (Bourdenx et al. 2011; Bernard 
et al. 2012). Results indicated that CER1/CER3 are mandatory for activity and that they rely on an interaction 
with their partner CYTB5s. By providing modifications upstream in E. coli that provide the required fatty 
aldehyde, the authors have been able to demonstrate that the difficulties are, at least in part, metabolic in nature; 
without CER3 - a putative acyl-CoA reductase - there is no substrate for CER1 to act on. Secondly, this analysis 
supports the assertion that CER1 catalyses the second stage of alkane biosynthesis and is therefore informative as 
to the metabolic routes for alkane biosynthesis in planta. 
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3.2 Manipulating chain length 
The chain length of alkanes and alkenes is one of the most crucial contributors to the properties of the fuel itself. 
Chain lengths in the region of C5 to C10 are the dominant chain length distribution found in petrol (gasoline) fuel 
blends, whereas C12 to C18 chain length are found in jet fuels and diesel. The ability to alter the chain length is 
therefore of great interest and has been demonstrated by several groups independently. 
The first group to demonstrate the ability to manipulate the alkane output was a team of undergraduate 
students from the University of Washington, competing in the Internationally Genetically Engineered Machines 
(iGEM) competition in 2011 (Harger et al. 2013).  They achieved this through a combination of genetic and media 
manipulations. To do this, the two-step cyanobacterial AAR/ADO pathway was expressed in E. coli. An 
additional modification was made through the addition of the gene encoding KASIII from Bacillus subtilis 
(fabHB). The KASIII enzyme from B. subtilis, unlike its E. coli counterpart, accepts a wider range of primer 
molecules into fatty acid biosynthesis. In addition to this genetic manipulation they also grew their E. coli in the 
presence of the three-carbon molecule propanoate. The presence of propanoate in E. coli growth media increases 
the pool of propanoyl-CoA molecules which are available for incorporation into fatty acid biosynthesis via the 
introduced KASIII. This ensured that - at least for some cycles - a three-carbon compound was incorporated into 
the fatty acid elongation cycle as well as the normal two carbon acetyl-CoA. The resultant fatty acids are therefore 
one carbon longer than the typical fatty acids. Following the Cn-1 rule for cyanobacterial AAR/ADO alkane 
biosynthesis, the combined effect of these genetic and media manipulations is the production of even- as well as 
odd-chain length alkanes. 
Entirely genetically encoded manipulations of alkane output have also been successful. For example, 
very short chain alkanes (e.g. propane) have been achieved in E. coli (Choi and Lee 2013; Kallio et al. 2014; 
Sheppard et al. 2016; Zhang et al. 2016). These manipulations are invariably made possible because of the switch 
from an acyl-ACP dependent system, to one that can exploit a manipulated fatty acid pool. In each instance, 
alkane production in E. coli whether via the FadD/ACR/CER1 manipulations of Choi and Lee (2013), or via CAR 
(Akhtar et al. 2013; Kallio et al. 2014), FAR (Howard et al. 2013), or ACR (Yan et al. 2016), was redirected to 
shorter chain alkanes by the inclusion of various thioesterases. 
 
3.3 Production of branched alkanes 
Branched chain alkanes (Fig. 1C) are crucial for fuel performance, preventing stacking (gelling) of fuel at cold 
temperatures or altitude. To date there are no elucidated natural pathways that produce mid-chain length branched 
alkanes suitable for retail fuels. To demonstrate that alkane biosynthesis can be directed towards such branched 
molecules E. coli expressing the FAR/ADO pathway was analysed for the ability to incorporate exogenous 
branched fatty acids into alkanes. The results indicated that branched molecules could be used by this pathway 
(Howard et al. 2013). Establishing these capabilities at the genetic level in E. coli is complicated by the fact that 
E. coli cannot naturally synthesise branched fatty acids (Choi et al. 2000; Smirnova and Reynolds 2001) though 
other bacteria, notably B. subtilis, do produce branched fatty acids (Oku and Kaneda 1998). The difficulty in 
establishing branched fatty acid biosynthesis in E. coli is two-fold. In vitro assembly of E. coli fatty acid 
biosynthesis indicates firstly that biosynthesis of branched fatty acids relies on the addition of appropriate 
branched primer molecules, and secondly that it relies on the addition of an alternative KASIII enzyme (Choi et 
al. 2000). To make branched fatty acids in E. coli therefore both the KASIII gene from B. subtilis needs to be 
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heterologously expressed, and suitable activity to generate the branched primer molecules, not naturally present in 
E. coli, is also required. For this to occur a further four genes are required that code for the multi-enzyme 
branched chain keto-dehydrogenase complex. Introducing all five genes leads to the production of branched fatty 
acids in E. coli, and the further addition of the FAR/ADO pathway results in the appearance of branched alkanes 
(Howard et al. 2013). The biosynthesis of short chain branched alkanes has also been established (Sheppard et al. 
2016). Taken together with the results discussed in 3.2, it is apparent that it is entirely possible to synthesise a 
range of linear and branched alkanes and alkenes of the chain lengths appropriate for petroleum-replacement 
biofuels that can be blended depending upon the required fuel properties. 
4. Research needs 
Further advances in the metabolic engineering of microbes for alkane biosynthesis has naturally shifted towards 
increasing yields and efficiencies of the biosynthetic processes. These may be considered in four broad areas: 
choice of organism and growth conditions; pathway engineering; enzyme engineering and the removal of the 
alkane product. In addition, further discovery of the genetics underlying alkane biosynthesis across all living 
systems will improve our understanding of the evolutionary pressures and biochemical diversity of alkane 
biosynthesis, with a resulting impact inspiring novel engineering strategies. 
 
4.1 Choice of chassis 
Whilst it is possible to relatively rapidly develop a proof of principle strain that produces a product of interest, it is 
far more challenging to develop a strain that meets commercial targets and fits within a biorefinery concept 
(Runguphan and Keasling 2014). The choice of cell factory is critical in the assessment of the industrial 
production of chemicals and recently there has been a consolidation and focus on a few industrial cell factories 
(Rumbold et al. 2009; Vickers et al. 2010; Hong and Nielsen 2012). The proven ability of cell factories such as E. 
coli, Corynebacterium glutamicum, Aspergillus niger, Pichia stipitis and S. cerevisiae, to perform robustly within 
industrial processes highlights their potential as industrial cell factories that may replace the current production of 
chemicals from crude oil in a sustainable way. The large scale industrial production of cellulosic ethanol using the 
yeast S. cerevisiae (“Project Liberty”: a joint venture between POET and DSM in the USA) shows the economic 
feasibility of using this cell factory for production of a relatively cheap, high volume commodity and is a success 
story related to the production of biofuels. 
The AAR/ADO pathway has been shown to operate in a wide range of microbes beyond E. coli, 
including non-AAR/ADO cyanobacterial species (Yoshino et al. 2015) and the chemoautotrophic bacterium 
Cupriavidus necator (Crepin et al. 2016). The latter is already grown as a commercial concern for production of 
bioplastics. Alkane biosynthesis has also been demonstrated in eukaryotic microbes such as S. cerevisiae (Bernard 
et al. 2012; Buijs et al. 2015; Kang et al. 2017) and in the filamentous fungus Aspergillus carbonarius (Sinha et al. 
2017). It is also important to note however that highly significant gains were made in the production of semi-
synthetic artemisinin not only from metabolic engineering strategies, but through optimisation of fermentation and 
extraction conditions (Westfall et al. 2012; Paddon et al. 2013). It is therefore a key challenge to metabolic 
engineers to consider not only the optimisation of the genetic components (choice of chassis and pathway 
engineering for example) but to include the optimisation of environmental (i.e. fermentation) conditions at the 
same time (Mukhopadhyay et al. 2008). 
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4.2 Pathway engineering 
Exploiting fatty acid biosynthesis for fuel production is advantageous, as many species have high carbon flux into 
these energy rich chemicals. Large increases in yields have been achieved in fatty acid and fatty acid-derived 
chemicals (reviewed in Mehrer et al. (2016)) and similar methods can be applied to increasing alkane biosynthesis 
efficiencies. There are early examples of this being applied successfully to microbial production of alkanes. 
Greater alkane titres have been achieved by manipulating the supply of substrates to the pathway and removal of 
competitive reactions (Cao et al. 2016; Song et al. 2016). In addition to these specific genetic manipulations, 
advances in computer guided metabolic engineering strategies will greatly assist these efforts (Patel et al. 2016). 
 
4.3 Enzyme engineering 
One means of addressing the need to improve system performance is through improvements to the performance of 
the enzymes responsible for catalysing the conversion from substrate (typically fatty acids) through to alkanes and 
alkenes. This is particularly important given the slow catalytic turnover of many of the enzymes. There are 
already examples of successful catalytic manipulations of both the ADO and OleT systems through their fusion to 
alternative reducing systems, or proteins capable of removing inhibiting compounds. As a peroxygenase, OleTJE 
uses H2O2 as its redox partner. However, excess reactive oxygen species can cause cellular damage and result in 
apoptosis. The cell therefore elicits many responses leading to rapid detoxification of reactive oxygen species and 
the removal of a driver of OleTJE alkene biosynthesis. To circumvent this studies have shown that OleTJE can 
perform H2O2-independent catalysis in vitro using either a flavodoxin/flavodoxin reductase system or a P450 
RhFRED reductase domain from Rhodococcus sp. (Liu et al. 2014). Furthermore, an OleT-RhFRED fusion has 
been shown to perform the same enzymatic activity, but supported by NADPH and oxygen, in an engineered fatty 
acid-overproducing strain of E. coli (Liu et al. 2014). An alternative strategy has been to fuse OleTJE with an 
alditol oxidase (AldO) from Streptomyces coelicolor (Matthews et al. 2017). The addition of AldO fused to 
OleTJE enables local generation of H2O2 from polyols (e.g. glycerol, sorbitol and xylitol) and an increased 
conversion of tetradecanoic acid to alkenes compared to direct addition of H2O2. For ADO, H2O2 has been shown 
to reversibly inhibit its catalytic activity. In order to circumvent this, the creation of a fusion protein consisting of 
ADO fused to a catalase capable of removing local H2O2 led to a dramatic five-fold improvement in catalytic 
turnover in vivo (Andre et al. 2013). In each instance these protein engineering efforts demonstrate that catalytic 
activity can be maintained and indeed improved when the proteins are assembled into larger structures providing 
optimism that different strategies for improving alkane production through protein manipulations can be achieved. 
 
4.4 Removal of product 
As with any metabolic engineering strategy, as pathways improve and titres of target molecules increase, it is 
likely that toxicity of the product will become a problem. This is an under explored area that will need to be 
developed to maximise outputs of petroleum-replica hydrocarbons. Manipulating efflux pumps to increase yield 
of target chemicals has been successful (Dunlop et al. 2011; Lennen et al. 2012; Kato et al. 2015). One of the key 
challenges identified in this research however, is the need to increase efflux pump efficiency and specificity, 
rather than simply increasing the number of pumps. The latter scenario can result in physiological damage to 
membrane integrity with deleterious effects on cell survival. 
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4.5 Gene Discovery 
Alkane biosynthesis is known in many living organisms yet only a small number of the biochemical pathways and 
the underlying genetic components are so far known. Elucidation of new pathways, for example in fungi 
(Gianoulis et al. 2012), mammalian waxes (Cheesbrough and Kolattukudy 1988), algae (Dennis and Kolattukudy 
1992), or bacteria, will enhance our understanding of the biochemistry and enzymology involved in alkane 
biosynthesis. This knowledge will broaden the choices available to bioengineers for developing suitable 
bioprocesses and facilitate greater forward engineering of pathways for commercial alkane biosynthesis. 
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Fig. 1 Examples of alkane and alkene molecules that can be synthesized by microbes. (a) Pentadecane 
(top) and heptadecane (bottom) are produced by cyanobacteria (Schirmer et al. 2010). (b) Alkenes include 1-
undecene (top) produced by Pseudomonas sp. (Rui et al. 2014) and the highly unsaturated very-long-chain alkene, 
3,6,9,12,15,19,22,25,28-hentriacontanonaene (bottom) produced by Shewanella sp. (Sukovich et al. 2010). (c) 
Branched alkanes bearing a methyl group (e.g., methyl tridecene illustrated) can be produced by the creation of 
synthetic metabolic pathways (Howard et al. 2013) 
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Fig. 2 Overview of bacterial alkane and alkene biogenesis. (a) Cyanobacterial conversion of fatty acyl-ACP 
molecules to Cn-1 alkanes and alkenes via acyl-ACP reductase (AAR) and aldehyde- deformylating oxygenase 
(ADO) (Schirmer et al. 2010). (b) Biosynthesis of VLC alkenes by the oleABCD gene cluster enzymes OleA, 
OleD, OleC and OleB (Beller et al. 2010; Sukovich et al. 2010; Sugihara et al. 2010; Christenson et al. 2017b). (c) 
Biosynthesis of mid-chain length alkenes directly from fatty acids accomplished using either OleT (Rude et al. 
2011) or UndA (Rui et al. 2014) 
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Fig. 3 Various substrates have been used as a starting point for alkane and alkene biosynthesis in genetically 
engineered pathways. These include fatty acyl-CoAs, fatty acyl-ACPs, and fatty acids. The enzymes that can 
exploit these substrates are a fatty acyl-CoA reductase (ACR) from Acinetobacter sp. (Yan et al. 2016), the 
carboxylic acid reductase (CAR) from Mycobacterium marinum (Akhtar et al. 2013), the fatty acid reductase 
(FAR) complex from Photorhabdus luminescens (Howard et al. 2013), OleT from Jeotgalicoccus sp. (Rude et 
al. 2011), and UndA from Pseudomonas sp. (Rui et al. 2014). With the exception of OleT and UndA, the other 
reactions generate a fatty aldehyde that can then be converted to an n-1 alkane or alkene using an aldehyde 
reductase from Arabidopsis thaliana (CER1) (Choi and Lee 2013), cyanobacterial aldehyde- deformylating 
oxygenase (ADO) (e.g., Akhtar et al. 2013; Howard et al. 2013), or CYP4G1 from Drosophila melanogaster (Qiu 
et al. 2012). Different permutations of these various steps have been successfully assembled, primarily in E. coli or 
S. cerevisiae 
 
 
